Search Result "secondary MDS/AML"

Implications of Somatic Mutations in the AML1/RUNX1 Gene in Myelodysplastic Syndrome (MDS): Future Molecular Therapeutic Directions for MDS

Journal: Current Cancer Drug Targets
Volume: 6 Issue: 6 Year: 2006 Page: 553-563
Author(s): Hironori Harada, Yuka Harada, Akiro Kimura

DNA Hypermethylation of Myeloid Cells, A Novel Therapeutic Target in MDS and AML

Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 5 Year: 2006 Page: 315-321
Author(s): Claudia I. Muller, Bjorn Ruter, H. Phillip Koeffler, Michael Lubbert

Implication of microRNAs in the Pathogenesis of MDS

Journal: Current Pharmaceutical Design
Volume: 18 Issue: 22 Year: 2012 Page: 3170-3179
Author(s): Jing Fang,Melinda Varney,Daniel T. Starczynowski

The Use of Plant Secondary Metabolites in the Treatment of Bacterial Diseases

Ebook: Therapeutic Use of Plant Secondary Metabolites
Volume: 1 Year: 2022
Author(s):
Doi: 10.2174/9789815050622122010010

Single Autosomal Trisomy in Acute Myeloid Leukemia and Myelodysplastic Syndrome

Journal: Current Genomics
Volume: 1 Issue: 2 Year: 2000 Page: 153-173
Author(s): S. K. Ma, T. S.K. Wan

Review Article

Genetic and Epigenetic Drug Targets in Myelodysplastic Syndromes

Journal: Current Pharmaceutical Design
Volume: 23 Issue: 1 Year: 2017 Page: 135-169
Author(s): Karmen Stankov,Suncica Stankov,Jasmina Katanic

Strategic Role of Nuclear Inositide Signalling in Myelodysplastic Syndromes Therapy

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2014 Page: 873-883
Author(s): Lucia Manzoli, Sara Mongiorgi, Cristina Clissa, Carlo Finelli, Anna Maria Billi, Alessandro Poli, Marilisa Quaranta, Lucio Cocco, Matilde Y. Follo

Clinical Impact of Hypomethylating Agents in the Treatment of Myelodysplastic Syndromes

Journal: Current Pharmaceutical Design
Volume: 22 Issue: 1 Year: 2016 Page: 2349-2357
Author(s): Carlo Finelli, Matilde Y. Follo, Marta Stanzani, Sarah Parisi, Cristina Clissa, Sara Mongiorgi, Marilena Barraco, Lucio Cocco

Stem Cell Transplantation in Pediatric Leukemia and Myelodysplasia: State of the Art and Current Challenges

Journal: Current Stem Cell Research & Therapy
Volume: 2 Issue: 1 Year: 2007 Page: 53-63
Author(s): Marc Bierings, James B. Nachman, C. Michel Zwaan, James B. Nachman

How Recent Advances in High-risk Myelodysplastic Syndrome Physiopathology May Impact Future Treatments

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5362-5373
Author(s): Thomas Cluzeau, Guillaume Robert, Arnaud Jacquel, Patrick Auberger

Previous   Next

Go To   Results 1 - 1 of 354

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


© 2025 Bentham Science Publishers | Privacy Policy